Loading clinical trials...
Loading clinical trials...
The Cerebral Amyloid angiopathy (CAA) is the leading cause of cortical hemorrhage after 65 years. The presence of cerebral infarction is also reported anatomically in the AAC. MRI studies of these inf...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondation Hôpital Saint-Joseph
NCT06935578 · CADASIL, CADASIL (Diagnosis), and more
NCT05473637 · Cerebral Small Vessel Diseases, Cadasil, and more
NCT03047369 · Leukodystrophy, White Matter Disease, and more
NCT05734378 · Cerebral Amyloid Angiopathy, Small Vessel Cerebrovascular Disease, and more
NCT03724136 · Alzheimer Disease, Alzheimer Dementia, and more
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions